Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Panobinostat is dosed at 0.5–1 mg/kg PO 3x/week in dogs, per Papich Handbook of Veterinary Drugs, 5th Ed. Panobinostat is used in dogs for Lymphoma (experimental). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Panobinostat in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Farydak
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.5–1 mg/kg | 3x/week | Per oncology protocol | Lymphoma (experimental) | Extrapolated | Papich Handbook of Veterinary Drugs, 5th Ed |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Pan-histone deacetylase (HDAC) inhibitor. Increases histone acetylation, altering gene expression to promote apoptosis and cell cycle arrest in neoplastic cells.
Experimental in veterinary oncology. Severe thrombocytopenia and GI toxicity expected. Monitor CBC closely. Limited veterinary data.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Panobinostat dose range in dogs, with cited source references: PO 0.5–1 mg/kg 3x/week. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Panobinostat in dogs: PO.
Cited course lengths for Panobinostat in dogs include: Per oncology protocol. Duration depends on the indication — match it to the specific dose rule in the table above.
Panobinostat is indicated in dogs for: Lymphoma (experimental).
These are general warnings for Panobinostat across species; consult the dog dosing table above for species-specific guidance. Experimental in veterinary oncology. Severe thrombocytopenia and GI toxicity expected. Monitor CBC closely. Limited veterinary data.
Why a species-specific page? Panobinostat pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.